Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
J Exp Bot ; 58(10): 2503-12, 2007.
Article in English | MEDLINE | ID: mdl-17526915

ABSTRACT

N-glycosylated proteins were isolated from Arabidopsis thaliana mature stems using affinity chromatography on Concanavalin A Sepharose, separated by 2D-electrophoresis and identified using nanoHPLC-MS/MS and MALDI-TOF MS. 102 glycoproteins were identified. 94% of these proteins were predicted by bioinformatics to be targeted to the secretory pathway and 87% of them were predicted to be localized in the cell wall or at the plasma membrane. 30% of these proteins belong to glycoside hydrolase (GH) families with some of them possibly involved in the hydrolysis of cell wall polysaccharides. The second major class of identified proteins comprises aspartyl and serine proteases. Other proteins are predicted to be oxido-reductases, contain interacting domains, are potentially involved in signalling or have an unknown function. This is, to our knowledge, the first survey of plant cell wall N-glycosylated proteins.


Subject(s)
Arabidopsis Proteins/metabolism , Arabidopsis/enzymology , Cell Wall/enzymology , Concanavalin A/chemistry , Glycoside Hydrolases/metabolism , Arabidopsis/growth & development , Arabidopsis Proteins/classification , Arabidopsis Proteins/physiology , Chromatography, Affinity/methods , Chromatography, High Pressure Liquid , Computational Biology , Glycoside Hydrolases/physiology , Glycosylation , Plant Stems/enzymology , Plant Stems/growth & development , Proteome , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
2.
Article in English | MEDLINE | ID: mdl-17270477

ABSTRACT

Using a monoclonal antibody against the entire C-terminal end of human APP(695) (643-695 sequence) and a monoclonal antibody directed against human beta[1-40] amyloid peptide (betaA), we show the existence of endogenous peptides proteolytically derived from APP in skin exudate of the non transgenic Xenopus laevis frog. The majority of the immunoreactivity is found associated with a 30 kDa molecular species. Biochemical fractionation followed by mass spectrometry identification allowed us to assign this molecular species to C-terminal APP fragments containing all or part of betaA. According to the nature of N- and C-terminal amino acids we identified endogenous beta-, gamma-, epsilon-secretase-like activities, caspase-like activity and numerous endogenous cleavage sites within the beta-amyloid sequence at same sites as those observed in human betaA sequence. All these homologies with human indicate that X. laevis skin exudate is a good natural model to study betaA metabolism. In this way, interestingly, we identified endogenous cleavages at prohormone convertase-like sites not yet described at the same sites in human. Finally, all identified peptide fragments were stably associated with a 20.2 kDa protein. These new observed features suggest new research pathways concerning human betaA metabolism and carriage of hydrophobic peptide fragments issued from APP processing.


Subject(s)
Amyloid beta-Protein Precursor/isolation & purification , Amyloid beta-Protein Precursor/metabolism , Exudates and Transudates/chemistry , Skin/chemistry , Xenopus Proteins/isolation & purification , Xenopus laevis , Amino Acid Sequence , Amyloid beta-Protein Precursor/immunology , Animals , Chromatography, Gel/methods , Chromatography, High Pressure Liquid/methods , Humans , Mass Spectrometry/methods , Molecular Sequence Data , Peptide Fragments/isolation & purification , Peptide Fragments/metabolism , Proprotein Convertases/metabolism , Sequence Analysis, Protein , Xenopus Proteins/immunology , Xenopus Proteins/metabolism
3.
Biochimie ; 89(4): 468-73, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17116355

ABSTRACT

Candida guilliermondii and human DNA topoisomerases I are inhibited by PL (pyridoxal), PLP (pyridoxal 5'-phosphate) and PLP-AMP (pyridoxal 5'-diphospho-5'-adenosine) (PL

Subject(s)
DNA Topoisomerases, Type I/chemistry , DNA Topoisomerases, Type I/metabolism , Pyridoxal/metabolism , Binding Sites , Humans , Models, Molecular , Protein Conformation
4.
J Med Chem ; 47(27): 6840-53, 2004 Dec 30.
Article in English | MEDLINE | ID: mdl-15615533

ABSTRACT

The eukaryotic topoisomerase II is involved in several vital processes, such as replication, transcription, and recombination. Many compounds interfering with the catalytic action of this enzyme are efficient in human cancer chemotherapy. We applied a methodology combining molecular modeling and virtual screening techniques to identify human topoisomerase II alphainhibitors. Data from structural biology and enzymatic assays together with a good background on the enzyme mechanism of action were helpful in the approach. A human topoisomerase II alpha model provided an insight into the structural features responsible for the activity of the enzyme. A protocol comprising several substructural and protein structure-based three-dimensional pharmacophore filters enabled the successful retrieving of inhibitors of the enzyme from large databases of compounds, thus validating the approach. A subset of protein structural features required for the enzyme inhibition at the protein-DNA interface were identified and incorporated into the pharmacophore models. Compounds sharing a DNA-intercalating chromophore and a moiety interfering with the protein active site emerged as good inhibitors.


Subject(s)
Enzyme Inhibitors/chemical synthesis , Topoisomerase II Inhibitors , Amino Acid Sequence , Antigens, Neoplasm , Binding Sites , DNA Topoisomerases, Type II/chemistry , DNA-Binding Proteins , Dimerization , Enzyme Inhibitors/pharmacology , Humans , Models, Molecular , Molecular Sequence Data , Molecular Structure , Sequence Alignment , Templates, Genetic
5.
Nucleic Acids Res ; 32(18): 5649-57, 2004.
Article in English | MEDLINE | ID: mdl-15494452

ABSTRACT

The present results demonstrate that pyridoxal, pyridoxal 5'-phosphate (PLP) and pyridoxal 5'-diphospho-5'-adenosine (PLP-AMP) inhibit Candida guilliermondii and human DNA topoisomerases I in forming an aldimine with the epsilon-amino group of an active site lysine. PLP acts as a competitive inhibitor of C.guilliermondii topoisomerase I (K(i) = 40 microM) that blocks the cleavable complex formation. Chemical reduction of PLP-treated enzyme reveals incorporation of 1 mol of PLP per mol of protein. The limited trypsic proteolysis releases a 17 residue peptide bearing a lysine-bound PLP (KPPNTVIFDFLGK*DSIR). Targeted lysine (K*) in C.guilliermondii topoisomerase I corresponds to that found in topoisomerase I of Homo sapiens (K532), Candida albicans (K468), Saccharomyces cerevisiae (K458) and Schizosaccharomyces pombe (K505). In the human enzyme, K532, belonging to the active site acts as a general acid catalyst and is therefore essential for activity. The spatial orientation of K532-PLP within the active site was approached by molecular modeling using available crystallographic data. The PLP moiety was found at close proximity of several active residues. PLP could be involved in the cellular control of topoisomerases IB. It constitutes an efficient tool to explore topoisomerase IB dynamics during catalysis and is also a lead for new drugs that trap the lysine general acid.


Subject(s)
Adenosine Diphosphate/analogs & derivatives , DNA Topoisomerases, Type I/chemistry , DNA Topoisomerases, Type I/drug effects , Enzyme Inhibitors/pharmacology , Lysine/drug effects , Pyridoxal Phosphate/analogs & derivatives , Pyridoxal Phosphate/pharmacology , Adenosine Diphosphate/pharmacology , Binding Sites , DNA Topoisomerases, Type I/metabolism , Enzyme Inhibitors/chemistry , Humans , Lysine/chemistry , Models, Molecular , Pyridoxal Phosphate/chemistry
6.
Biochemistry ; 30(41): 9940-7, 1991 Oct 15.
Article in English | MEDLINE | ID: mdl-1680395

ABSTRACT

The salt requirement for the catalysis of DNA relaxation carried out by a eukaryotic DNA topoisomerase I from Candida was reexamined with plasmid pBR322 DNA. Two levels of analysis were considered: the initial velocity of the overall reaction and the mode of this reaction (processivity vs distributivity). When looking at the monovalent salts from the first level, the replacement of Cl- by Glu- or Asp- greatly enhanced the salt range over which the enzyme was active. Moreover, the initial velocity reached an optimal value for a higher salt concentration in this case. For the cationic counterpart, K+ was a little more effective than Na+ and much more so than NH4+. Addition of 4 mM magnesium chloride affected both the range and the optimum of the initial velocity differentially, depending upon the monovalent salt, but with a general stimulating tendency. On the other hand, when the Mg2+ salt was varied, substitution of chloride by aspartate enhanced the optimum of the initial velocity for a fixed KCl concentration. In addition, magnesium aspartate (MgAsp2) and magnesium glutamate (MgGlu2) allowed the reaction to occur even without monovalent salt and over an extended range. Magnesium was also shown to directly interact with the general catalysis (Kd = 2.5 mM). From the second level of analysis, the presence of Mg2+ (except with NH4Glu), the substitution of Cl- by Glu- or Asp-, and a lower monovalent salt concentration than that used for the velocity optimum were required to promote the processive mode.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Aspartic Acid/pharmacology , Candida/enzymology , DNA Topoisomerases, Type I , DNA, Bacterial/drug effects , Glutamates/pharmacology , Magnesium/pharmacology , Ammonia/pharmacology , Candida/drug effects , Catalysis , DNA, Bacterial/chemistry , Glutamic Acid , Kinetics , Nucleic Acid Conformation/drug effects , Plasmids , Potassium/pharmacology , Sodium/pharmacology
7.
Biochimie ; 71(4): 497-503, 1989 Apr.
Article in English | MEDLINE | ID: mdl-2503054

ABSTRACT

Three enzymes partially purified that catalyze respectively the transamination of L-norleucine, 4-aminobutyrate and delta-aminovalerate with alpha-ketoglutarate as aminoacceptor were characterized and isolated from L-lysine adapted cell of Candida guilliermondii var. membranaefaciens. The transaminases have a maximum activity in the pH range of 7.8-8.5 and at 55 degrees C, 45 degrees C and 40 degrees C respectively. alpha-Ketoglutarate and to a lesser extent pyridoxal-5'-phosphate were effective protecting agents against rise in temperature. The enzymes exhibit absorption maximum at 280 nm, 330 nm and 410 nm. The fact that L-norleucine-leucine aminotransferase, 4-aminobutyrate aminotransferase and delta-aminovalerate aminotransferase are strongly induced by growing the yeast Candida on L-lysine suggests new hypothetic pathways for the catabolism of L-lysine where the main substrate of each aminotransferase could be an intermediary metabolite.


Subject(s)
Candida/enzymology , Lysine/metabolism , Transaminases/metabolism , 4-Aminobutyrate Transaminase/metabolism , Candida/drug effects , Enzyme Induction , Hydrogen-Ion Concentration , Lysine/pharmacology , Substrate Specificity , Temperature , Transaminases/isolation & purification
8.
Eur J Biochem ; 167(1): 141-7, 1987 Aug 17.
Article in English | MEDLINE | ID: mdl-3622507

ABSTRACT

A new enzyme which catalyzes the transamination of L-norleucine (2-aminohexanoic acid) and L-leucine with 2-oxoglutarate was purified to homogeneity from cells of Candida guilliermondii var. membranaefaciens. The relative molecular mass determined by gel filtration was estimated to be close to 100,000. The transaminase behaved as a dimer which consists of two subunits identical in molecular mass (Mr 51,000). The enzyme has a maximum activity in the pH range of 8.0-8.5 and at 55 degrees C. 2-Oxoglutarate, and to a lesser extent pyridoxal 5'-phosphate, were effective protecting agents against increasing temperature. The enzyme exhibits absorption maximum at 330 nm and 410 nm. L-Norleucine, and L-leucine to a lesser extent, are the best amino donors with 2-oxoglutarate as amino acceptor. The Km values for L-norleucine, L-leucine and 2-oxoglutarate determined from the Lineweaver-Burk plot were 1.8 mM, 6.6 mM and 2.0 mM respectively. A ping-pong bi-bi mechanism of inhibition with alternative substrates is found when the enzyme is in the presence of both L-norleucine and L-leucine. The inhibitory effect of various amino acid analogs on the transamination reaction between L-norleucine and 2-oxoglutarate was studied and Ki values were determined.


Subject(s)
Candida/enzymology , Transaminases/isolation & purification , Hydrogen-Ion Concentration , Kinetics , Leucine/metabolism , Norleucine/metabolism , Pyridoxal Phosphate/analysis , Spectrophotometry , Substrate Specificity , Temperature , Valine/metabolism
9.
Biochemistry ; 25(19): 5507-12, 1986 Sep 23.
Article in English | MEDLINE | ID: mdl-3778871

ABSTRACT

A new enzyme that catalyzes the transamination of delta-aminovalerate with alpha-ketoglutarate was purified to homogeneity from adapted cells of Candida guilliermondii var. membranaefaciens. The relative molecular mass determined by gel filtration was estimated to be close to 118,000. The transaminase behaved as a dimer with two similar subunits in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The enzyme has a maximum activity in the pH range of 7.8-8.5 and at 40 degrees C. alpha-Ketoglutarate and to a lesser extent pyridoxal 5'-phosphate were effective protecting agents toward temperature raising. The enzyme exhibits absorption maximum at 330 and 410 nm. The enzyme catalyzes the transamination between omega-amino acids and alpha-ketoglutarate. delta-Aminovaleric acid is the best amino donor. The Km values for delta-aminovalerate, alpha-ketoglutarate, and pyridoxal 5'-phosphate determined from the Lineweaver-Burk plot were 4.9 mM, 3.6 mM, and 22.7 microM, respectively. The inhibitory effect of various amino acids analogues on the transamination reaction between delta-aminovalerate and alpha-ketoglutarate was studied, and Ki values were determined.


Subject(s)
Candida/enzymology , Transaminases/isolation & purification , Kinetics , Molecular Weight , Spectrophotometry , Substrate Specificity , Transaminases/metabolism
10.
Eur J Biochem ; 156(3): 589-96, 1986 May 02.
Article in English | MEDLINE | ID: mdl-3699025

ABSTRACT

An enzyme which catalyzes the transamination of 4-aminobutyrate with 2-oxoglutarate was purified 588-fold to homogeneity from Candida guilliermondii var. membranaefaciens, grown with 4-aminobutyrate as sole source of nitrogen. An apparent relative molecular mass of 107,000 was estimated by gel filtration. The enzyme was found to be a dimer made up of two subunits identical in molecular mass (Mr 55,000). The enzyme has a maximum activity in the pH range 7.8-8.0 and a temperature optimum of 45 degrees C. 2-Oxoglutarate protects the enzyme from heat inactivation better than pyridoxal 5'-phosphate. The absorption spectrum of the enzyme exhibits two maxima at 412 nm and 330 nm. The purified enzyme catalyzes the transamination of omega-amino acids; 4-aminobutyrate is the best amino donor and low activity is observed with beta-alanine. The Michaelis constants are 1.5 mM for 2-oxoglutarate and 2.3 mM for 4-aminobutyrate. Several amino acids, such as alpha,beta-alanine and 2-aminobutyrate, are inhibitors (Ki = 38.7 mM, Ki = 35.5 mM and Ki = 33.2 mM respectively). Propionic and butyric acids are also inhibitors (Ki = 3 mM and Ki = 2 mM).


Subject(s)
4-Aminobutyrate Transaminase/isolation & purification , Candida/enzymology , 4-Aminobutyrate Transaminase/antagonists & inhibitors , 4-Aminobutyrate Transaminase/metabolism , Alanine/pharmacology , Aminobutyrates/pharmacology , Butyrates/pharmacology , Butyric Acid , Electrophoresis, Polyacrylamide Gel , Hydrogen-Ion Concentration , Isoelectric Point , Kinetics , Molecular Weight , Propionates/pharmacology , Pyridoxal Phosphate/analysis , Substrate Specificity , Temperature
11.
Rev Pneumol Clin ; 40(4): 251-4, 1984.
Article in French | MEDLINE | ID: mdl-6100624

ABSTRACT

Bronchiolo-alveolar carcinoma is a rare primary lung tumour, which is difficult to diagnose by cytological techniques. This peripheral tumour, which develops on pre-existing alveolar walls, is not visible on bronchial endoscopy and brushing is often negative. The cellular material derived from aspiration or expectoration is characterised by numerous papillae, without any cytonuclear criteria of malignancy. The differential diagnosis is very difficult with reactive papillary hyperplasia and various forms of chronic bronchial inflammation. Transparietal aspiration lung biopsy facilitates the diagnosis of glandular carcinoma: the material examined corresponds to pathological tissue, as the biopsy is performed under image intensifier control. An inflammatory lesion is excluded by the rich cellularity and by the presence of architectural features of malignancy: cohesive and three-dimensional clumps of papillary tumour cells. The early cytological diagnosis of bronchiolo-alveolar and primary bronchiolar carcinomas of the lung by transparietal aspiration biopsy can allow the surgical cure of certain localised forms.


Subject(s)
Adenocarcinoma, Bronchiolo-Alveolar/diagnosis , Lung Neoplasms/diagnosis , Adenocarcinoma, Bronchiolo-Alveolar/pathology , Adult , Biopsy, Needle , Cytodiagnosis , Female , Humans , Lung/pathology , Lung Neoplasms/pathology , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...